CD19-negative relapse with an apparent cytogenetic shift after blinatumomab-induced measurable residual disease clearance in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Masuho Saburi, Reina Nagano, Rika Maruyama, Masanori Sakata, Hiroyuki Takata, Eiichi Ohtsuka

doi:10.1016/j.lrr.2026.100600

CrossrefInfo card

CD19-negative relapse with an apparent cytogenetic shift after blinatumomab-induced measurable residual disease clearance in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Masuho Saburi, Reina Nagano, Rika Maruyama, Masanori Sakata, Hiroyuki Takata, Eiichi Ohtsuka

Leukemia Research Reports · 2026 · 26 · 100600

DOI: 10.1016/j.lrr.2026.100600 ↗

Abstract Bibliographic details

Abstract

No abstract available.

Bibliographic details

Authors: Masuho Saburi, Reina Nagano, Rika Maruyama, Masanori Sakata, Hiroyuki Takata, Eiichi Ohtsuka
Journal: Leukemia Research Reports
Year of publication: 2026
Volume / Issue: 26
Pages: 100600
Publisher: Elsevier BV
DOI: 10.1016/j.lrr.2026.100600
ISSN: 2213-0489
Source: Crossref

Knowledge that fits your work.

From a free start through personal literature research to the complete Research Suite.

View plans →

Are all publisher full texts included?

No. Bibliographic records, abstracts and full texts are different content types. Full-text availability depends on the source, open access and your existing licences. An EUVIMED plan does not replace additional publisher rights.